340 related articles for article (PubMed ID: 26777740)
41. Evidence-based imaging of pancreatic malignancies.
Kinney T
Surg Clin North Am; 2010 Apr; 90(2):235-49. PubMed ID: 20362784
[TBL] [Abstract][Full Text] [Related]
42. Characterization of small solid tumors in the pancreas: the value of contrast-enhanced harmonic endoscopic ultrasonography.
Kitano M; Kudo M; Yamao K; Takagi T; Sakamoto H; Komaki T; Kamata K; Imai H; Chiba Y; Okada M; Murakami T; Takeyama Y
Am J Gastroenterol; 2012 Feb; 107(2):303-10. PubMed ID: 22008892
[TBL] [Abstract][Full Text] [Related]
43. Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites.
Sadowski SM; Neychev V; Millo C; Shih J; Nilubol N; Herscovitch P; Pacak K; Marx SJ; Kebebew E
J Clin Oncol; 2016 Feb; 34(6):588-96. PubMed ID: 26712231
[TBL] [Abstract][Full Text] [Related]
44. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
[TBL] [Abstract][Full Text] [Related]
45. Staging pancreatic carcinoma by computed tomography.
Montejo Gañán I; Ángel Ríos LF; Sarría Octavio de Toledo L; Martínez Mombila ME; Ros Mendoza LH
Radiologia (Engl Ed); 2018; 60(1):10-23. PubMed ID: 29078990
[TBL] [Abstract][Full Text] [Related]
46. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?
Kuhn FP; Hüllner M; Mader CE; Kastrinidis N; Huber GF; von Schulthess GK; Kollias S; Veit-Haibach P
J Nucl Med; 2014 Apr; 55(4):551-8. PubMed ID: 24491410
[TBL] [Abstract][Full Text] [Related]
47. Comparison between CT and CEUS in the diagnosis of pancreatic adenocarcinoma.
D'Onofrio M; Crosara S; Signorini M; De Robertis R; Canestrini S; Principe F; Pozzi Mucelli R
Ultraschall Med; 2013 Aug; 34(4):377-81. PubMed ID: 23023447
[TBL] [Abstract][Full Text] [Related]
48. Usefulness of contrast-enhanced transabdominal ultrasound for tumor classification and tumor staging in the pancreatic head.
Grossjohann HS; Rappeport ED; Jensen C; Svendsen LB; Hillingsø JG; Hansen CP; Nielsen MB
Scand J Gastroenterol; 2010 Aug; 45(7-8):917-24. PubMed ID: 20441527
[TBL] [Abstract][Full Text] [Related]
49. Morphological analysis and differentiation of benign cystic neoplasms of the pancreas using computed tomography and magnetic resonance imaging.
Grieser C; Heine G; Stelter L; Steffen IG; Rothe JH; Walter TC; Fischer C; Bahra M; Denecke T
Rofo; 2013 Mar; 185(3):219-27. PubMed ID: 23196834
[TBL] [Abstract][Full Text] [Related]
50. FDG PET/CT findings of solid pseudopapillary tumor of the pancreas with CT and MRI correlation.
Dong A; Wang Y; Dong H; Zhang J; Cheng C; Zuo C
Clin Nucl Med; 2013 Mar; 38(3):e118-24. PubMed ID: 23354028
[TBL] [Abstract][Full Text] [Related]
51. Differentiation of intraductal papillary mucinous neoplasms from other pancreatic cystic masses: comparison of multirow-detector CT and MR imaging using ROC analysis.
Song SJ; Lee JM; Kim YJ; Kim SH; Lee JY; Han JK; Choi BI
J Magn Reson Imaging; 2007 Jul; 26(1):86-93. PubMed ID: 17659551
[TBL] [Abstract][Full Text] [Related]
52. Comparison of diffusion-weighted MR imaging and multidetector-row CT in the detection of liver metastases in patients operated for pancreatic cancer.
Holzapfel K; Reiser-Erkan C; Fingerle AA; Erkan M; Eiber MJ; Rummeny EJ; Friess H; Kleeff J; Gaa J
Abdom Imaging; 2011 Apr; 36(2):179-84. PubMed ID: 20563868
[TBL] [Abstract][Full Text] [Related]
53. Multimodality imaging of pancreatic cancer-computed tomography, magnetic resonance imaging, and positron emission tomography.
Raman SP; Horton KM; Fishman EK
Cancer J; 2012; 18(6):511-22. PubMed ID: 23187837
[TBL] [Abstract][Full Text] [Related]
54. Gadobenate dimeglumine-enhanced 3.0-T MR imaging versus multiphasic 64-detector row CT: prospective evaluation in patients suspected of having pancreatic cancer.
Koelblinger C; Ba-Ssalamah A; Goetzinger P; Puchner S; Weber M; Sahora K; Scharitzer M; Plank C; Schima W
Radiology; 2011 Jun; 259(3):757-66. PubMed ID: 21436084
[TBL] [Abstract][Full Text] [Related]
55. Current update on primary pancreatic lymphoma.
Anand D; Lall C; Bhosale P; Ganeshan D; Qayyum A
Abdom Radiol (NY); 2016 Feb; 41(2):347-55. PubMed ID: 26830418
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of focal pancreatic masses: comparison of mangafodipir-enhanced MR imaging and contrast-enhanced helical CT.
Schima W; Függer R
Eur Radiol; 2002 Dec; 12(12):2998-3008. PubMed ID: 12439582
[TBL] [Abstract][Full Text] [Related]
57. Pancreatic imaging: current and emerging technologies.
Nichols MT; Russ PD; Chen YK
Pancreas; 2006 Oct; 33(3):211-20. PubMed ID: 17003640
[TBL] [Abstract][Full Text] [Related]
58. Optimal Imaging Modalities for the Diagnosis and Staging of Periampullary Masses.
Al-Hawary MM; Kaza RK; Francis IR
Surg Oncol Clin N Am; 2016 Apr; 25(2):239-53. PubMed ID: 27013362
[TBL] [Abstract][Full Text] [Related]
59. Comparison between MRI and CEUS in the follow-up of patients with blunt abdominal trauma managed conservatively.
Miele V; Piccolo CL; Sessa B; Trinci M; Galluzzo M
Radiol Med; 2016 Jan; 121(1):27-37. PubMed ID: 26253384
[TBL] [Abstract][Full Text] [Related]
60. Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT.
Schima W; Függer R; Schober E; Oettl C; Wamser P; Grabenwöger F; Ryan JM; Novacek G
AJR Am J Roentgenol; 2002 Sep; 179(3):717-24. PubMed ID: 12185052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
